Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$3.07
-0.170 (-5.25%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $2.94 $3.73 Friday, 10th May 2024 CLRB stock ended at $3.07. This is 5.25% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 6.56% from a day low at $3.05 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Mar 03, 2022 $0.520 $0.520 $0.480 $0.490 211 300
Mar 02, 2022 $0.510 $0.510 $0.490 $0.500 109 500
Mar 01, 2022 $0.500 $0.520 $0.490 $0.500 171 100
Feb 28, 2022 $0.470 $0.520 $0.470 $0.510 231 700
Feb 25, 2022 $0.510 $0.540 $0.470 $0.480 266 000
Feb 24, 2022 $0.440 $0.500 $0.440 $0.500 169 300
Feb 23, 2022 $0.490 $0.520 $0.490 $0.500 126 400
Feb 22, 2022 $0.490 $0.510 $0.460 $0.490 154 300
Feb 18, 2022 $0.520 $0.530 $0.480 $0.490 420 000
Feb 17, 2022 $0.550 $0.550 $0.520 $0.520 124 400
Feb 16, 2022 $0.560 $0.590 $0.530 $0.530 168 400
Feb 15, 2022 $0.550 $0.570 $0.540 $0.550 97 000
Feb 14, 2022 $0.570 $0.580 $0.550 $0.550 50 800
Feb 11, 2022 $0.580 $0.600 $0.550 $0.570 187 200
Feb 10, 2022 $0.580 $0.610 $0.580 $0.600 184 000
Feb 09, 2022 $0.580 $0.600 $0.570 $0.580 251 100
Feb 08, 2022 $0.590 $0.610 $0.560 $0.590 201 300
Feb 07, 2022 $0.580 $0.610 $0.530 $0.580 127 300
Feb 04, 2022 $0.570 $0.600 $0.540 $0.570 157 500
Feb 03, 2022 $0.600 $0.610 $0.560 $0.570 215 800
Feb 02, 2022 $0.650 $0.670 $0.590 $0.610 129 700
Feb 01, 2022 $0.600 $0.700 $0.590 $0.630 346 300
Jan 31, 2022 $0.570 $0.630 $0.560 $0.600 197 800
Jan 28, 2022 $0.530 $0.640 $0.520 $0.590 325 900
Jan 27, 2022 $0.570 $0.600 $0.520 $0.520 280 800
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT